We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Effectively spreading the word about clinical trial results could improve awareness and support for new drugs, but many companies are not making the best communication decisions, according to a new study that recommends improvements.
Novartis and Schering AG are reevaluating the filing strategy for their experimental cancer treatment PTK/ZK after preliminary data from a Phase III trial showed the drug probably won’t extend patients’ lives.
Schering AG has signed a collaboration and licensing agreement with AstraZeneca that will focus on the development of selective glucocorticoid receptor agonists (SEGRAs), a new class of anti-inflammatory agents.
Pharmaceutical companies that coordinate the role of their firms’ IT processes with their clinical development and marketing procedures will be better prepared to overcome internal and external challenges that may limit business success, a technology expert recently said.
Drugmakers hoping to get some more mileage out of their cholesterol-lowering drugs by marketing them as treatments for dementia might need to pursue a new strategy.
Drug and device manufacturers would be required to submit clinical trial results to a federally managed database under legislation introduced by two prominent House Democrats.
A prominent cancer research institution has decided after a lengthy evaluation process to restart a clinical trial measuring the effects of Pfizer’s Celebrex against lung cancer.
An elderly woman enrolled in a clinical trial of Pfizer’s antiepileptic drug Lyrica suffered a serious adverse event after abruptly discontinuing the medication — an incident that researchers say could indicate the drug poses withdrawal problems.
Pharmaceutical firms developing new nonsteroidal anti-inflammatory drugs (NSAIDs) should conduct long-term trials to test their products for cardiovascular risks, a top FDA official says.